Patent details

EP2919766 Title: SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

Basic Information

Publication number:
EP2919766
PCT Application Number:
US2013070012
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137988408
PCT Publication Number:
WO2014078486
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
French Title of Invention:
FORMES POSOLOGIQUES A LIBERATION PROLONGEE DE RUXOLITINIBE
German Title of Invention:
DOSIERUNGSFORMEN VON RUXOLITINIB MIT VERZÖGERTER FREISETZUNG
SPC Number:

Dates

Filing date:
14/11/2013
Grant date:
26/05/2021
EP Publication Date:
23/09/2015
PCT Publication Date:
22/05/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2021
EP B1 Publication Date:
26/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/05/2021
 
 

Name:
Incyte Holdings Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
05/07/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
NI, Yong
Address:
United States (US)

2

Name:
PARIKH, Bhavnish
Address:
United States (US)

3

Name:
YELESWARAM, Krishnaswamy
Address:
United States (US)

4

Name:
ERICKSON-VIITANEN, Susan
Address:
United States (US)

5

Name:
WILLIAMS, William V.
Address:
United States (US)

Priority

1

Priority Number:
201261726893 P
Priority Date:
15/11/2012
Priority Country:
United States (US)

2

Priority Number:
201361769408 P
Priority Date:
26/02/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61K 31/4045;

Publication

European Patent Bulletin

1

Issue number:
202121
Publication date:
26/05/2021
Description:
Grant (B1)

2

Issue number:
202125
Publication date:
23/06/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
05/07/2021 Outgoing Correspondence 1
05/07/2021 Power Of Attorney 1